Company profile

AccuTheranostics company profile

AccuTheranostics™ is a biotechnology company focused on the business of individualizing chemotherapy thereby dramatically improving outcomes for cancer patients. AccuTheranostics™ uses proprietary sophisticated technologies to provide patient-specific cancer diagnostic and prognostic information to oncologists in hospitals and oncology practices. AccuTheranostics™ is a leader in delineating the entire cellular composition of solid tumors. Specimens are shipped in AccuTheranostics’™ holding medium to our headquarters in Buffalo, New York where they undergo disaggregation, are subjected to drugs, single and in combination, and chemoresistance/sensitive profile is determined. The results will be provided within days of receiving the specimen to determine optimum treatment. AccuTheranostics™ is..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Operating status
Closed
Company type
For Profit
Employee range
00011-00050 employees
Founded
2012-01-01

Headquarters

Headquarters
Spicer, Minnesota, United States
Postal code
14203
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Convertible Note / 2017-01-01
Investors
1
Lead investors
1
Closed on
2024-01-24

Founders and investors

Lead investors

Launch NY

Investors

Launch NY

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.